NM_000307.5:c.506C>T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000307.5(POU3F4):c.506C>T(p.Pro169Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000148 in 1,206,558 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 44 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P169P) has been classified as Likely benign.
Frequency
Consequence
NM_000307.5 missense
Scores
Clinical Significance
Conservation
Publications
- nonsyndromic genetic hearing lossInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- X-linked mixed hearing loss with perilymphatic gusherInheritance: XL Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- mitochondrial non-syndromic sensorineural hearing lossInheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
- choroideremia-deafness-obesity syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| POU3F4 | NM_000307.5 | c.506C>T | p.Pro169Leu | missense_variant | Exon 1 of 1 | ENST00000644024.2 | NP_000298.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| POU3F4 | ENST00000644024.2 | c.506C>T | p.Pro169Leu | missense_variant | Exon 1 of 1 | NM_000307.5 | ENSP00000495996.1 | |||
| ENSG00000279437 | ENST00000625081.1 | n.385G>A | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| ENSG00000307072 | ENST00000823276.1 | n.654G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | ||||||
| ENSG00000307072 | ENST00000823277.1 | n.601G>A | non_coding_transcript_exon_variant | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.000133 AC: 15AN: 112563Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.000322 AC: 54AN: 167897 AF XY: 0.000272 show subpopulations
GnomAD4 exome AF: 0.000149 AC: 163AN: 1093995Hom.: 0 Cov.: 31 AF XY: 0.000111 AC XY: 40AN XY: 359899 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000133 AC: 15AN: 112563Hom.: 0 Cov.: 24 AF XY: 0.000115 AC XY: 4AN XY: 34711 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Pro169Leu variant in POU3F4 has been identified by our laboratory in one mal e individual with hearing loss (LMM-unpublished data), but was absent from large population studies. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Pro169Leu variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.506C>T (p.P169L) alteration is located in exon 1 (coding exon 1) of the POU3F4 gene. This alteration results from a C to T substitution at nucleotide position 506, causing the proline (P) at amino acid position 169 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at